Back
Editas Medicine Stock Price Chart

Here's the Best Day to Buy Nvidia
Click here to see the green days for 5 major stocks today.
Sell
43
EDIT
Editas Medicine
Last Price:
$1.79
Seasonality Move:
8.84%
7 Day Trial
ALL ACCESS PASS
$
7

Trump's Tariffs Are Reshaping Markets
Grade any 3 stocks FREE to see if your portfolio is at risk.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EDIT is experiencing slight buying pressure.
Editas Medicine Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.75 | Buy |
20-day SMA: | 1.59 | Buy |
50-day SMA: | 1.44 | Buy |
200-day SMA: | 2.19 | Sell |
8-day EMA: | 1.75 | Buy |
20-day EMA: | 1.63 | Buy |
50-day EMA: | 1.35 | Buy |
200-day EMA: | 0.6 | Buy |
Editas Medicine Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.13 | Buy |
Relative Strength Index (14 RSI): | 60.59 | Buy |
Chaikin Money Flow: | 216541 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.42 - 1.74) | Buy |
Bollinger Bands (100): | (1.17 - 1.75) | Buy |
Editas Medicine Technical Analysis
May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Editas Medicine Stock
Is Editas Medicine Stock a Buy?
-
Editas Medicine share price is 1.82 while EDIT 8-day simple moving average is 1.75, which is a Buy signal.
-
The stock price of EDIT is 1.82 while Editas Medicine 20-day SMA is 1.59, which makes it a Buy.
-
Editas Medicine 50-day simple moving average is 1.44 while EDIT share price is 1.82, making it a Buy technically.
-
EDIT stock price is 1.82 and Editas Medicine 200-day simple moving average is 2.19, creating a Sell signal.
EDIT Technical Analysis vs Fundamental Analysis
Sell
43
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine a Buy or a Sell?
-
Editas Medicine stock is rated a SellThe current Editas Medicine [EDIT] share price is $1.82. The Score for EDIT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
Editas Medicine Stock Info
Market Cap:
152.4M
Price in USD:
1.82
Share Volume:
866.2K
Editas Medicine 52-Week Range
52-Week High:
6.22
52-Week Low:
0.91
Sell
43
Editas Medicine (EDIT)
is a Sell
Editas Medicine Share Price Forecast
-
What is the Editas Medicine stock price today?The Editas Medicine stock price is 1.82 USD today.
-
Will EDIT stock go up or go down?Editas Medicine> share price is forecast to RISE/FALL based on technical indicators
-
Is Editas Medicine overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Editas Medicine is overvalued.
Is Editas Medicine Stock a Buy?
-
Editas Medicine share price is 1.82 while EDIT 8-day exponential moving average is 1.75, which is a Buy signal.
-
The stock price of EDIT is 1.82 while Editas Medicine 20-day EMA is 1.63, which makes it a Buy.
-
Editas Medicine 50-day exponential moving average is 1.35 while EDIT share price is 1.82, making it a Buy technically.
-
EDIT stock price is 1.82 and Editas Medicine 200-day simple moving average is 0.60, creating a Buy signal.
Fundamental Analysis of Editas Medicine
Is Editas Medicine a good investment?
-
Analysts estimate an earnings increase this quarter of $0.44 per share, an increase next quarter of $0.07 per share, an increase this year of $0.81 per share, and an increase next year of $0.74 per share.
Technical Analysis of Editas Medicine
Should I short Editas Medicine stock?
-
EDIT Moving Average Covergence Divergence (MACD) indicator is 0.13, suggesting Editas Medicine is a Buy
-
Editas Medicine Relative Strength Index (RSI) is 60.59, which suggest Editas Medicine is overbought
-
The Bollinger Bands (25) for Editas Medicine is (1.42 - 1.74), which suggest Editas Medicine is a Buy
-
The Bollinger Bands (100) for Editas Medicine is (1.17 - 1.75), which suggest Editas Medicine is a Buy
* Editas Medicine stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.